Bharat Biotech's Covid-19 nasal vaccine to cost ₹800 in pvt market, ₹325 for govt supplies
The iNCOVACC vaccine received Indian drug regulator's approval to be used as a booster dose for the adult population.
covid 19 vaccine
December 2022
September 2022
July 2022
May 2022
April 2022
March 2022
January 2022
Bharat Biotech's intranasal Covid-19 vaccine to be available on Co-WIN app from today
The vaccine will be available on the Co-WIN platform for persons aged above 18 years for primary 2 dose schedule, homologous booster doses, from Friday evening.
Bharat Biotech's intranasal Covid-19 vaccine approved for restricted use
It’s India's first nasal vaccine against Covid-19. Health minister Mansukh Mandaviya says it’ll further strengthen country's fight against pandemic
Biological E bets on vaccines, specialty injectables and branded generics
Hyderabad-based Biological E Limited (BE), which recently launched its indigenously made Covid-19 vaccine Corbevax, will focus on new vaccines, specialty injectables, and branded generics.
$19.3 million to Bharat Biotech consortium for ‘variant-proof’ Covid vaccine
The funding seeks to establish preclinical and clinical proof of concept for a vaccine designed to provide protection against all known SARS-CoV-2 variants.
Serum's Poonawalla pitches for global pandemic treaty for free flow of vaccines
India has learned a lot and is in a stronger and better position to face any future wave or future pandemics, says Adar Poonawalla.
Krishna Ella's Sapigen, Science Ministry partner for malaria, Covid-19 nasal vaccine
Technology Development Board and Bharat Biotech will put in ₹200 crore each to create a continuous corpus of ₹400 crore for the partnership project.
Review vaccine policy to safest vaccine: Experts to govt
India should review its vaccine policy to favour the safest vaccine of all the vaccines that have been approved for the coronavirus, says expert.
Budget 2022: CII for 1% CSR levy to fund Covid-19 booster shots
The industry body has urged the central government to raise the CSR levy by an additional 1% for a period of 12 months to provide Covid-19 booster vaccines to the community.
Vaccine anniversary: India administers 157 crore Covid-19 doses
While 65.65 crore Indians have taken both the doses, first dose has been taken by 91.08 crore people.
